(Q42906627)

10 November 2017

title

DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes (English)

1 reference

10 November 2017

0 references

Yanchun Li

2

1 reference

10 November 2017

Yan Huang

5

1 reference

10 November 2017

Nga N. Ta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843518

13 July 2024

Corinne A. Schuyler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843518

13 July 2024

Maria F. Lopes-Virella

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843518

13 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20843518

13 July 2024

publication date

26 August 2010

1 reference

full work available at URL

10 November 2017

https://api.elsevier.com/content/article/PII:S0021915010007124?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

https://api.elsevier.com/content/article/PII:S0021915010007124?httpAccept=text/plain

13 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

13 July 2024

1 reference

10 November 2017

volume

213

1 reference

10 November 2017

issue

2

1 reference

10 November 2017

page(s)

429-435

1 reference

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

10 November 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/IJC.2910170504

Role of CD26/dipeptidyl peptidase IV in human T cell activation and function

1

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells

13 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells

13 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes

13 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes

13 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase

13 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

13 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

13 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

13 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation

13 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation

13 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Pre-exposure to high glucose augments lipopolysaccharide-stimulated matrix metalloproteinase-1 expression by human U937 histiocytes

13 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.

13 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Fluorogenic substrate [Ala-Pro]2-cresyl violet but not Ala-Pro-rhodamine 110 is cleaved specifically by DPPIV activity: a study in living Jurkat cells and CD26/DPPIV-transfected Jurkat cells

13 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug

13 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys

13 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

13 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

13 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations

13 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Pioglitazone inhibits MMP-1 expression in vascular smooth muscle cells through a mitogen-activated protein kinase-independent mechanism

13 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway:: an implication of CRP involvement in plaque destabilization

13 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Mitogen-activated protein kinase proteins regulate LPS-stimulated release of pro-inflammatory cytokines and prostaglandins from human gestational tissues

13 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

13 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.

13 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells

13 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

New insights into plaque stabilisation by lipid lowering.

13 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease

13 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits

13 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway

13 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ATHEROSCLEROSIS.2010.08.064

13 July 2024

Identifiers

1 reference

release_e5uco24z6fevjhs3ixqlm5d4oa

10 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e5uco24z6fevjhs3ixqlm5d4oa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference